Evidence map›Paper›PMID 17049610›Full record

ArticleJournal of inorganic biochemistry2007

Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CLpro by molecular modeling.

Donghua Hu, Chen Shao, Wei Guan, Zhongmin Su, Jiazhong Sun

Abstract read
In one paragraph

Article in Journal of inorganic biochemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. An Androsterone-HChemPlusChem · 2021
    Article
  5. Human coronaviruses and therapeutic drug discovery.Infectious diseases of poverty · 2021
    Review
  6. Article
  7. Article
  8. Molecular simulation study of the binding mechanism of [α-PTiChinese science bulletin = Kexue tongbao · 2010
    Article
  9. Article
  10. Preparation and antibacterial efficacy of bamboo charcoal/polyoxometalate biological protective material.Microporous and mesoporous materials : the official journal of the International Zeolite Association · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Donghua HuInstitute of Functional Material Chemistry, Faculty of Chemistry, Northeast Normal University, Changchun 130024, China.
Chen Shao
Wei Guan
Zhongmin Su
Jiazhong Sun

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ti-containing alpha-Keggin polyoxometalates (POMs) have been proved with properties of both anti-tumor and anti-HIV (human immunodeficiency virus). The potential anti-SARS (severe acute respiratory syndrome) activity of the POMs [alpha-PTi(2)W(10)O(40)](7-) isomers was investigated in this paper by molecular modeling method. The SARS 3c like protease, namely the SARS 3CL(pro) is the key function protease for virus replication as well as transcription and thus can be taken as one of the key targets for anti-SARS drug design. Affinity/Insight II was used to explore possible binding locations for POMs/3CL(pro) interaction. Charges in the POMs were obtained from density-functional theory (DFT) method. The results show that POMs bind with 3CL(pro) in the active site region with high affinity; POMs are more prone to bind with 3CL(pro) than with some organic compounds; for the POMs/3CL(pro)complex, the OTi(2) in POMs is the vital element for electrostatic interaction, and the electrostatic binding energy is strong enough to keep the complex stable.

Indexed as

Models, MolecularCoronavirus 3C ProteasesCysteine EndopeptidasesTitaniumViral ProteinsCoronavirus 3C ProteasesCysteine EndopeptidasesTitaniumViral Proteins

Identifiers

PMID17049610
PMCPMC7112571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.